Sun Pharma Advanced Research Company Ltd

NSE: SPARC · BSE: 532872 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹196.73
Market cap: ₹6,384 Cr
Revenue (annual): ₹1,879 Cr
Net profit (annual): ₹1,553 Cr
P/E (TTM): 4.0×Sector 47.4×
Promoter holding: 65.67%+0.00% QoQ
FII holding: 3.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Annual General Meeting 3 Promoter Reclassification 2 Fund Raise 2 Business Update 2 Board Meeting Date 2 Merger & Restructuring 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 May 2026 20:39 IST NSE

Fund Raise

Sun Pharma Advanced Research Company Fund Raise of ₹150 Cr

SPARC received ₹149.99 Crore from Shanghvi Finance via a preferential allotment of 3,85,10,000 warrants. The capital infusion strengthens the company's financial position for future growth.

Value: ₹150.0 Cr

Read the filing ↗

19 May 2026 12:32 IST NSE

Fund Raise

Sun Pharma Advanced Research Company Fund Raise of ₹600 Cr

SPARC allotted 3.85 crore convertible warrants at ₹155.80 each to Shanghvi Finance on a preferential basis. The ₹599.99 Crore raise strengthens capital for future growth.

Value: ₹600.0 Cr

Read the filing ↗